Affordable Access

deepdyve-link
Publisher Website

Impact of intestinal microbiota in patients with heart failure: A systematic review.

Authors
  • Formiga, Francesc1
  • Ferreira Teles, Cristiana Isabel2
  • Chivite, David2
  • 1 Servicio de Medicina Interna, Hospital Universitario de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España. Electronic address: [email protected]
  • 2 Servicio de Medicina Interna, Hospital Universitario de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Type
Published Article
Journal
Medicina Clínica
Publisher
Elsevier
Publication Date
Nov 29, 2019
Volume
153
Issue
10
Pages
402–409
Identifiers
DOI: 10.1016/j.medcli.2019.06.006
PMID: 31416611
Source
Medline
Keywords
Language
Spanish
License
Unknown

Abstract

Heart failure (HF) is a chronic disease with significant morbidity and mortality. Substantial haemodynamic changes such as hypoperfusion and intestinal congestion can alter the composition of the intestinal microbiota in patients with HF. The aim of this systematic review is to evaluate the influence of bowel function in patients with HF and the possible role of the intestinal microbiota in the development and evolution of the latter. Eleven studies were included in the review. These studies seem to confirm that HF patients present with substantial abnormalities in the composition of their intestinal microbiota. Trimethylamine N-oxide is identified as a key mediator between the alterations in the intestinal microbiota and HF and correlates with worse prognosis in HF patients. In conclusion, patients with HF present with frequent abnormalities in the characteristics of their intestinal microbiota, which may play a role in the prognosis of the disease. Copyright © 2019 Elsevier España, S.L.U. All rights reserved.

Report this publication

Statistics

Seen <100 times